A systematic review of pharmacovigilance systems in developing countries using the WHO pharmacovigilance indicators
HY Garashi, DT Steinke, EI Schafheutle - Therapeutic innovation & …, 2022 - Springer
Background In the context of the growth of pharmacovigilance (PV) among developing
countries, this systematic review aims to synthesise current research evaluating developing …
countries, this systematic review aims to synthesise current research evaluating developing …
Pharmacovigilance in high-income countries: current developments and a review of literature
The world bank has classified 80 economies based on their Gross National Income (GNI)
per capita as High-Income. European Medicines Agency (EMA), Food and Drug …
per capita as High-Income. European Medicines Agency (EMA), Food and Drug …
Factors associated with spontaneous adverse drug reaction reporting among healthcare professionals in Vietnam
TT Le, TTH Nguyen, C Nguyen, NH Tran… - Journal of clinical …, 2020 - Wiley Online Library
What is known and objective Under‐reporting is a major drawback of a voluntary adverse
drug reaction reporting system in pharmacovigilance. However, little is known about …
drug reaction reporting system in pharmacovigilance. However, little is known about …
[HTML][HTML] Data-Driven Identification of Factors That Influence the Quality of Adverse Event Reports: 15-Year Interpretable Machine Learning and Time-Series Analyses …
Background: The completeness of adverse event (AE) reports, crucial for assessing putative
causal relationships, is measured using the vigiGrade completeness score in VigiBase, the …
causal relationships, is measured using the vigiGrade completeness score in VigiBase, the …
Overview of pharmacovigilance system in Vietnam: lessons learned in a resource-restricted country
KD Nguyen, PT Nguyen, HA Nguyen, A Roussin… - Drug Safety, 2018 - Springer
Drug safety issues in developing countries are complex and sensitive, and health authorities
cannot always simply implement decisions from developed countries because the health …
cannot always simply implement decisions from developed countries because the health …
[PDF][PDF] Adverse drug reaction reporting and development of pharmacovigilance systems in Bosnia and Herzegovina, Croatia, Serbia, and Montenegro: a retrospective …
Aim To compare individual case safety reports (ICSR) rates and characteristics between
Croatia, Serbia, Montenegro, and Bosnia and Herzegovina (B&H). Methods This …
Croatia, Serbia, Montenegro, and Bosnia and Herzegovina (B&H). Methods This …
Knowledge, attitude and practice of Malaysian healthcare professionals toward adverse drug reaction reporting: a systematic review
S Balan - International Journal of Pharmacy Practice, 2021 - academic.oup.com
Objective Healthcare professionals have an important role in ensuring that adverse drug
reactions are well documented and reported. The key determinants of adverse drug …
reactions are well documented and reported. The key determinants of adverse drug …
Current status of pharmacovigilance regulatory structures, processes, and outcomes in the Asia‐Pacific region: Survey results from 15 countries
Purpose Regulatory discrepancies may exist in pharmacovigilance (PV) structure, process,
and outcome status worldwide. Our study's objective was to survey the current status of PV …
and outcome status worldwide. Our study's objective was to survey the current status of PV …
Strengths and weaknesses of the pharmacovigilance systems in three Arab countries: a mixed-methods study using the WHO pharmacovigilance indicators
H Garashi, D Steinke, E Schafheutle - International Journal of …, 2022 - mdpi.com
Using the WHO pharmacovigilance (PV) indicators as a framework, this study aimed to
explore the structures, processes, and outcomes of three Arab countries'(Jordan, Oman, and …
explore the structures, processes, and outcomes of three Arab countries'(Jordan, Oman, and …
A survey on pharmacovigilance activities in Asean and selected non-Asean countries, and the use of quantitative signal detection algorithms
CL Chan, PS Ang, SC Li - Drug Safety, 2017 - Springer
Abstract Introduction Most Countries have pharmacovigilance (PV) systems in place to
monitor the safe use of health products. The process involves the detection and assessment …
monitor the safe use of health products. The process involves the detection and assessment …